Impact of extracardiac vascular disease on acute prognosis in patients who undergo percutaneous coronary interventions (data from the Blue Cross & Blue Shield of Michigan Cardiovascular Consortium [BMC2])

This publication has 11 references indexed in Scilit:

• The Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) Collaborative Quality Improvement Initiative in Percutaneous Coronary Interventions
  Journal of Interventional Cardiology, 2002
• Development of a Multicenter Interventional Cardiology Database: The Blue Cross Blue Shield of Michigan Cardiovascular Consortium (BMC2) Experience
  Journal of Interventional Cardiology, 2002
• Predictors of stroke in the modern era of coronary artery bypass grafting: a case control study
  The Annals of Thoracic Surgery, 2002
• Peripheral Arterial Disease Detection, Awareness, and Treatment in Primary Care
  JAMA, 2001
• Influence of Peripheral Vascular Occlusive Disease on the Morbidity and Mortality of Coronary Artery Bypass Grafting
  Japanese Circulation Journal, 2000
• Increased Incidence of Periprocedural Complications Among Patients With Peripheral Vascular Disease Undergoing Myocardial Revascularization in the Bypass Angioplasty Revascularization Investigation
  Circulation, 1999
• Long-Term Prognostic Value of Clinically Evident Noncoronary Vascular Disease in Patients Undergoing Coronary Revascularization in the Bypass Angioplasty Revascularization Investigation (BARI)
  The American Journal of Cardiology, 1998
• A Critical Look at Methods for Handling Missing Covariates in Epidemiologic Regression Analyses
  American Journal of Epidemiology, 1995
• Surgical Therapy for Coronary Artery Disease Among Patients With Combined Coronary Artery and Peripheral Vascular Disease
  Circulation, 1995
• Coronary morphologic and clinical determinants of procedural outcome with angioplasty for multivessel coronary disease. Implications for patient selection. Multivessel Angioplasty Prognosis Study Group.
  Circulation, 1990